MEST and breast cancer: In addition, miR-335 and its host gene, MEST, are silenced in association with CGI methylation in hepatocellular carcinoma (HCC) [31], and replacement of miR-335 exerts tumor suppressive effects in lung, pancreatic and breast cancer cells, which is suggestive of the therapeutic potential of miR-335 [32–34].